FDA grants emergency authorization for COVID prevention drug for the immunocompromised

  • 📰 Newsweek
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 52%

United States Headlines News

United States Latest News,United States Headlines

The FDA stressed that the new monoclonal antibody therapy 'is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended.'

) has authorized the use of a non-vaccine therapy to prevent COVID-19 infections in immunocompromised people.

The Food and Drug Administration issued an emergency use authorization for AstraZeneca’s Evusheld on Wednesday. The AstraZeneca logo is pictured with a syringe in the forefront in this picture taken on November 17, 2020."Vaccines have proven to be the best defense available against COVID-19," Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a.

Evusheld is administered as two intramuscular injections, given in immediate succession, and may be effective at preventing COVID-19 infections for up to six months. Thel that formed the basis of the therapy's authorization found that it was 83 percent effective in preventing infections among mostly high-risk participants.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 468. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktailThe U.S. Food and Drug Administration on Wednesday authorized the use of AstraZeneca's antibody cocktail to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines. 🤣🤣🤣🤣🤣🤡🤡🤡🤡🤡 😎😎 this is terrible news
Source: Reuters - 🏆 2. / 97 Read more »

European travel powerhouse and 6 other places at 'very high' risk for Covid-19, CDC saysThe CDC has put five places in Europe -- including France and Portugal -- on its list of destinations for 'very high' Covid-19 travel risk. Find out what other destinations were also moved to Level 4. No UK? Definitely should be. America should be number one on the list
Source: CNN - 🏆 4. / 95 Read more »

NYC Sets First-Ever Covid-19 Vaccine Mandate For Private BusinessesMayor Bill de Blasio said the mandate will take effect at the end of the month. good luck
Source: Forbes - 🏆 394. / 53 Read more »

Stephen Colbert Discusses Covid-19 On Luxury Cruise Liners And Unaware PassengersTonight on the Late Show With Stephen Colbert, the host talks about Covid-19 on the high seas. While Delta, and Omicron variants rage through the population, there has been a spike in regular Covid…
Source: DEADLINE - 🏆 109. / 63 Read more »

Covid-19 live updates: U.S. coronavirus cases approach 50 millionThe omicron variant of the virus, which is possibly more contagious than the widespread delta variant, had been found in 19 U.S. states as of Monday. Get vaccinated folks!
Source: washingtonpost - 🏆 95. / 72 Read more »

Here’s How Covid-19 Vaccine Makers Plan To Tackle OmicronI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com No go9d the vaccine with RNAm for atletic!because dont' t are true and save peolple! Can you explain this
Source: Forbes - 🏆 394. / 53 Read more »